Director
Neoletix Biotech
Lawrenceville, Georgia, United States
Qi Li, Chief Executive Officer,Beijing Neoletix Biological Technology Co. Ltd.
PH.D. in Biochemistry, University of Cambridge, Cambridge, UK and M.D., Tianjin Medical University, China.
Previous Positions: Assistant Professor of Baylor College of Medicine. Department Head of Protein Chemistry, Novo Nordisk Research US. Senior Fellow of FDA.
Beijing Neoletix Biological Technology (Neoletix) Co. Ltd. is a clinical-stage biotech company committed to innovative research and development in hemostasis, thrombosis, rare diseases, as well as therapies that can eradicate certain types of cancer tumors.
PB1106 - A novel and versatile platform for high expression of different FVIII modalities
Tuesday, June 25, 2024
13:45 – 14:45 ICT